Detailansicht

Wissensnetz

Person

Franziska Eckert (1980-)

Ärztin

Name	Franziska Eckert
Zeit	1980- (Lebensdaten)
Ort	Traunstein (Geburtsort) Deutschland
Akademischer Grad bzw. Titel	Dr. med. (Univ. Tübingen) (2007)
Beruf	Ärztin (charakteristischer Beruf)
Weitere Angaben	Habil. Fach Strahlentherapie an der Univ. Tübingen
Datensatztyp	Person
GND-Nummer	13427623X
Datensatz-ID	13427623X
Beteiligt an alle anzeigen FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation? Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score Evaluation der Kombination aus Radiotherapie und Immuntherapie im humanisierten Mausmodell Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK) Charakterisierung des neuen Akt-interagierenden Proteins AIP Charakterisierung des neuen Akt-interagierenden Proteins AIP

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Franziska Eckert (1980-)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score

Evaluation der Kombination aus Radiotherapie und Immuntherapie im humanisierten Mausmodell

Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK)

Charakterisierung des neuen Akt-interagierenden Proteins AIP

Charakterisierung des neuen Akt-interagierenden Proteins AIP